Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04304950 · ClinicalTrials.gov registry record · Phase 4
Chronotherapy in Inflammatory Bowel Disease
A Phase 4 study, sponsored by Rush University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 28
- Enrollment target
NCT04304950 is a Phase 4 study that has completed, run by Rush University Medical Center. The registered enrollment target is 28 participants.
The verdict
NCT04304950, a Phase 4 study, has completed, sponsored by Rush University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 28 participants
- Enrollment target
Study Summary
This study aims to determine if there is any difference in the efficacy of Inflammatory Bowel Disease (IBD) medication and disease outcomes when taken in the morning or in the evening. The IBD medications being observed are azathioprine and 6-mercaptopurine. The study team believes that there may be a benefit to taking the medication at a certain time of day. To test this theory the study asks participants who are already taking either azathioprine or 6-mercaptopurine for IBD to take the medication consistently at either the morning or in the evening based on when they currently take their medication. Participation is up to 10 weeks +/- 3 days. There will be 2 study visits where the participant will be asked to fill in questionnaires related to their IBD symptoms, their sleep habits, sleep quality, and general health information followed by a blood draw.
Interventions
- DRUG Evening Group
- DRUG Morning Group
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2016-04-25 |
| Est. Completion | 2023-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04304950
The ClinicalTrials.gov registry entry for NCT04304950 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rush University Medical Center, which has 320 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Evening Group is the first listed.
NCT04304950 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04304950 about?
NCT04304950 is a clinical study titled "Chronotherapy in Inflammatory Bowel Disease". This study aims to determine if there is any difference in the efficacy of Inflammatory Bowel Disease (IBD) medication and disease outcomes when taken in the morning or in the evening. The IBD medications being observed are azathioprine and 6-mercaptopurine. The study team believes that there may be...
What is the current status of trial NCT04304950?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 28 participants. The study started on 2016-04-25. Estimated completion is 2023-04.
What interventions are being tested in trial NCT04304950?
The interventions under investigation include: Evening Group (DRUG), Morning Group (DRUG).
Who is sponsoring clinical trial NCT04304950?
This trial is sponsored by Rush University Medical Center, which has 320 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.